Evidence for polymerase gamma, POLG1 variation in reduced mitochondrial DNA copy number in Parkinson's disease

Abstract Background It remains unclear whether the mtDNA content is related to the clinicopathological prognosis in Parkinson's disease (PD). Methods/Results We analyzed the copy number of mtDNA using quantitative real-time PCR in 414 cases with PD and 231 healthy subjects from mainland of Chin...

Full description

Saved in:
Bibliographic Details
Published in:Parkinsonism & related disorders 2015-03, Vol.21 (3), p.282-286
Main Authors: Gui, Ya-Xing, Xu, Zhong-Ping, Lv, Wen, Zhao, Jin-Jia, Hu, Xing-Yue
Format: Article
Language:English
Subjects:
Aged
DNA Copy Number Variations - genetics
DNA Mutational Analysis
DNA Polymerase gamma
DNA-Directed DNA Polymerase - genetics
Female
Genotype
Humans
Male
Middle Aged
Mitochondrial DNA
Neurology
Parkinson Disease - genetics
Parkinson's diseases
POLG1
Statistics as Topic
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background It remains unclear whether the mtDNA content is related to the clinicopathological prognosis in Parkinson's disease (PD). Methods/Results We analyzed the copy number of mtDNA using quantitative real-time PCR in 414 cases with PD and 231 healthy subjects from mainland of China. The level of mtDNA was significantly decreased in PD patients' peripheral blood as compared to that of healthy controls (p  A in POLG1 along with mutations in POLG1 had a significantly lower copy number of mtDNA than those of PD patients without POLG1 alterations. Conclusions Our results provided evidence for a significantly lower of mtDNA copy number in PD patients and POLG1 variation for reducing mtDNA copy number in PD.
ISSN:1353-8020
1873-5126
DOI:10.1016/j.parkreldis.2014.12.030